Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors. (Q48565611)

12 February 2018

title

Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors. (English)

1 reference

12 February 2018

1 reference

Björn Schilström

1

1 reference

12 February 2018

Vladimir B Ivanov

series ordinal

2

1 reference

12 February 2018

Charlotte Wiker

series ordinal

3

1 reference

12 February 2018

Torgny H Svensson

series ordinal

4

1 reference

12 February 2018

language of work or name

English

0 references

publication date

26 April 2006

1 reference

12 February 2018

published in

Neuropsychopharmacology

1 reference

12 February 2018

volume

32

1 reference

12 February 2018

issue

1

1 reference

12 February 2018

page(s)

43-53

1 reference

12 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301087

exact match

0 references

cites work

Galantamine for treatment-resistant schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms a homo-oligomeric channel blocked by α-BTX

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Selective loss of central cholinergic neurons in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Donepezil modulates nicotinic receptors of substantia nigra dopaminergic neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Regulation of dopamine release by impulse flow and by autoreceptors as studied by in vivo voltammetry in the rat striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Nicotinic effects on the firing pattern of midbrain dopamine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Activation of midbrain presumed dopaminergic neurones by muscarinic cholinergic receptors: an in vivo electrophysiological study in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Prevalence of smoking among psychiatric outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Precise localization of alpha7 nicotinic acetylcholine receptors on glutamatergic axon terminals in the rat ventral tegmental area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Nicotinic acetylcholine involvement in cognitive function in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Stimulation of the pedunculopontine tegmental nucleus in the rat produces burst firing in A9 dopaminergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Long-term potentiation of excitatory inputs to brain reward areas by nicotine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Adjuvant galantamine administration improves negative symptoms in a patient with treatment-refractory schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Dual effects of nicotine on dopamine neurons mediated by different nicotinic receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Nicotine and food induced dopamine release in the nucleus accumbens of the rat: putative role of alpha7 nicotinic receptors in the ventral tegmental area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Effects of galantamine, a nicotinic allosteric potentiating ligand, on nicotine-induced catecholamine release in hippocampus and nucleus accumbens of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Alpha-adrenoceptor modulation hypothesis of antipsychotic atypicality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Cholinergic drugs for Alzheimer's disease enhance in vitro dopamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Metabotropic glutamate and muscarinic cholinergic receptor-mediated preferential inhibition of N-methyl-D-aspartate component of transmissions in rat ventral tegmental area

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Laterodorsal tegmental stimulation elicits dopamine efflux in the rat nucleus accumbens by activation of acetylcholine and glutamate receptors in the ventral tegmental area

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

Prefrontal dopamine D1 receptors and working memory in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

7 January 2021

Normalization of auditory physiology by cigarette smoking in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

7 January 2021

Burst stimulation of the medial forebrain bundle selectively increases Fos-like immunoreactivity in the limbic forebrain of the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

7 January 2021

Cholinergic inhibition of ventral midbrain dopamine neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

7 January 2021

The control of firing pattern in nigral dopamine neurons: burst firing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

7 January 2021

Inhibitory action of muscarinic agonists on neurons in the rat laterodorsal tegmental nucleus in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

7 January 2021

Acetylcholine release in ventral tegmental area by hypothalamic self-stimulation, eating, and drinking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

7 January 2021

Putative role of presynaptic alpha7* nicotinic receptors in nicotine stimulated increases of extracellular levels of glutamate and aspartate in the ventral tegmental area

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

7 January 2021

Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301087

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301087

1 reference

12 February 2018

PubMed ID

16641937

1 reference

12 February 2018